This page contains a Flash digital edition of a book.
UK COUNTRY FOCUS


UK LIFE SCIENCES


WHERE NEXT? T


By: ABHI (Association of British Healthcare Industries)


he challenges facing the Western world’s healthcare systems have been well documented in recent years — ageing populations, increase in chronic diseases and higher obesity rates. Until recently the UK Government increased spending at


a rate that was able to meet the increased demand generated by these challenges. The global economic crash of 2008 and the subsequent recession forced governments everywhere to look at their spending and find areas where savings can be made. In the UK the government has made a number of cuts and slowed down the rate of growth in healthcare spending. Commentators now predict that the NHS needs to save £20bn by 2015. This has led to a reduction in NHS activity, which in turn has heightened the need for UK SMEs to expand their horizons and look abroad for new markets to facilitate their growth. The UK government has acknowledged that SMEs have the potential to drive UK economic growth. Prime Minster David Cameron has said supporting SMEs to export could help the UK economy grow


008 ARAB HEALTH MAGAZINE UK SUPPLEMENT 2012


by £30bn. 99% of companies in the UK medical device sector are SMEs, the types of companies Mr Cameron is talking about when he highlights the potential for growth. If we look in more detail at the make-up of the sector we see that the there are over 3,000 companies employing 64,000 people with a combined turnover of £15bn. In terms of output, the UK medical device industry produces a broad and diverse range of products that support the NHS. These range from the highly innovative - implantable devices such as pacemakers and orthopaedic implants, right through to hospital consumables such as drapes and gowns. In 2011 the largest sectors in industry were single use technology,


wound care, orthopaedic devices, in vitro diagnostic technology and implantable devices. Other notable and innovative sectors include the medical imaging sector, drug delivery and infection control. New companies from industry have traditionally been spin-outs from universities based on relationships with local hospitals with growth


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84